We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Criticizes Sanofi-Aventis for Failing to Act on Ketek Trial
FDA Criticizes Sanofi-Aventis for Failing to Act on Ketek Trial
November 14, 2007
An FDA warning letter citing sanofi-aventis for failing to respond to reports of problems with a clinical trial for its antibiotic Ketek and oversee the trial’s investigator has rekindled a congressional investigation into the drug’s approval process.